Newsletters
- All
- Incentives
- Jobs
- Media & Graphics
- PK & PK-PD
- R&D Insight
- Wonkish
- Y2017
- Y2018
- Y2019
- Y2020
- All
- Incentives
- Jobs
- Media & Graphics
- PK & PK-PD
- R&D Insight
- Wonkish
- Y2017
- Y2018
- Y2019
- Y2020
Let’s help Alan Carr do a COVID-19 point insight survey
Dear All, I promise that the next email will be all about the 25 Mar 2020 NHS England webinar on …
Send a note to your congressman/woman today!
Dear All, If you are a US citizen, you have an opportunity right now (as in today/tomorrow) to push for …
Tetraphase sold for $14m … and $600m goes up in smoke!
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter): Wonkish and long note alert … top-up your coffee …
Sweden to test an access-focused model for new antibiotics: Contracting for Availability
Dear All: Sweden has been a steady supporter of work on incentives for antibiotics for over a decade – as …
NHS England antibiotic procurement pilot project: Update webinar on 25 Mar 2020
Dear All, This email was just today received from the team leading the NHS England antibiotic procurement project (go here …
WHO R&D-focused consultancy: Data coordinator for next WHO pipeline review
Dear All, As you know, WHO has been driving a series of clinical and preclinical pipeline reviews (go here for …
FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)
Dear All (detailed and wonkish note alert … lots of thinking out loud … get some coffee and settle in!), …
What does an antibiotic cost to develop? What is it worth? How to afford it?
Dear All (long, wonkish note alert!): Today we have a 3-part discussion of cost and value with this summary 3-part …
Glaxo seeks buyer for two of its older antibiotics / AMR podcasts to share
Heads-up … numerous changes in the meeting calendar: Lots of new events as well as rescheduling of previously announced events. …
Consultancy at WHO: manage a fund for implementation of AMR-focused actions / 17 Mar 2020 deadline
Dear All, A fascinating job posting has gone up from WHO and the full text is just below my signature. …
Chemicals vs. drugs (Part 3): XKCD has the final word
Dear All, As a coda to the two newsletters on Chemicals, Drugs, and Halicin (link and link), XKCD gets the …
WHO consultancy to support AMR-related messaging / 2 Mar 2020 deadline!
Dear All, WHO has just posted a job opening for a consultant in Geneva to help with spreading the word …
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
Dear All (wonkish note alert!), The recent newsletter on chemicals, drugs, and halicin (link, see also a follow-up newsletter here) …
Chemicals vs. drugs (Part 1): The end of bacitracin / the buzz around halicin
This newsletter has a follow-up here. Dear All, Today’s theme is a 2-part journey that could be subtitled “Many are …
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
Note: See also these related newsletters: 13 Jan 2019 (link) on DTR as part of the language of resistance and …
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
Dear All (wonk-ish note alert and also with particular thanks as always to Kevin Outterson for helping to refine this …
FDA workshop: Animal models to support antibacterial development (5 Mar 2020)
Dear All (moderately long note alert; be sure to note the new list of funding opportunities just below my signature), …
Jobs x 2: Singapore (Clinical Research Network Director) and WHO (home-based consultant)
Dear All, Two fascinating job opportunities have appeared. Even if you’re not looking for a job, the job descriptions tell …
Mandatory reading: Alan Carr’s Jan 2020 Antibacterial and Antifungal market review
Dear All, Alan Carr has just released his Jan 2020 review of the antibacterial and antifungal market (link). For those …
News from Davos 2020: Some positive signs, but overall a fragile antibiotic market at a tipping point
Dear All (and heads-up for a rather lengthy and wonkish note … settle in for the details), Last week saw …
